Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (3603)	12/13/1997 5:05:00 PM
From: Evan Dimmer	Read Replies (2) \| Respond to of 23519

I think that no matter what happens to Viagra, we benefit. Here are two examples: 1. Viagra is a flop, news is released, and VVUS stock skyrockets (that would be nice). 2. Viagra works, but like everyone says, for cases that aren't serious. This brings more people in to look at the drugs, we find more serious cases, and we get more scripts. I have heard nobody even mention the possibility that Viagra could compete with MUSE in regards to seriousness of condition of ED. Have I not been looking hard enough?